CHICAGO, Nov. 4, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include CVS Caremark (NYSE: CVS), NYSE Euronext (NYSE: NYX), Target (NYSE: TGT), Nordstrom (NYSE: JWN) and Macy's (NYSE: M).
(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Thursday's Analyst Blog:
Greek Turmoil Dominates Headlines
We have a slew of economic and earnings reports on the docket today, but the Greek turmoil will likely continue to dominate the headlines. On the economic front, we got better-than-expected weekly Jobless Claims numbers, raising hopes for a favorable showing from Friday's non-farm payroll report.
We also have a surprise interest rate cut from the European Central Bank, likely indicating a new monetary policy course for the central bank under Mario Draghi, who replaced Jean-Claude Trichet only three days ago. A little later, we get the September Factory Orders and the October ISM Service Sector Index reading.
The big wait on the U.S. economic front now is for the Friday labor market report. But irrespective of the quality of that report, the overall economic picture has improved markedly over the last few weeks. Had it not been for the re-emergence of the Euro-zone fears following the Greek referendum gambit, all the major macro worries have started easing in recent days. The solid October rally reflected this improved macro backdrop, but the renewed Euro-zone uncertainty threatens to derail it.
European leaders meeting in the French city of Cannes have tightened the screws on Greece's Prime Minister Papandreou. They have suspended payment of the next tranche of bailout money till the completion of the referendum and given him an ultimatum to decide whether his country wanted to stay within the common currency or not.
As a result, the referendum will likely take place on or around December 4, almost a month ahead of what the Greeks had originally indicated. But the referendum plan needs to get approved by the Greek parliament before it could take place. And the government may not have the votes in parliament to get its approval. The question at this stage is whether the Greek government will survive if its referendum plan fails to get parliamentary approval. The government's fall would mean fresh general elections, hardly a solution to the current problem.
On the domestic labor market front, we got a better-than-expected read on weekly Jobless Claims. Initial claims dropped a bigger than expected 9K to 397K, while the prior week's level was revised upwards to 406K from the original 402K. The four-week average dropped 2K to 404.5K. The overall trend on the initial Jobless Claims front has been favorable, as they have fallen in four of the last six weeks. However, the extent of the decline has been quite anemic, with the initial claims number stubbornly refusing to fall below the 400K level. This week's drop below the 400K notwithstanding, initial claims have remained above the 400K level consistently since March, except for two weeks.
On the earnings front, we got a modest EPS beat from CVS Caremark (NYSE: CVS) on in-line revenue. We got a similar performance from exchange operator NYSE Euronext (NYSE: NYX), a modest EPS beat on in-line revenue.
In other corporate news, we got weaker-than-expected October same-store sales numbers from a number of major retailers this morning, including Target (NYSE: TGT), Nordstrom (NYSE: JWN) and Macy's (NYSE: M).
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
[email protected]
http://www.zacks.com
SOURCE Zacks Investment Research, Inc.
Share this article